Literature DB >> 8521769

Pharmacological management of erectile dysfunction.

F Montorsi1, G Guazzoni, P Rigatti, G Pozza.   

Abstract

Pharmacological treatment of erectile dysfunction includes all therapeutic modalities based on the use of erectogenic drugs, regardless of the route of administration. Intracavernous vasoactive injection therapy is the most commonly used treatment for erectile dysfunction. Most patients respond to intracavernous injection of either single or multiple vasoactive drugs. Major adverse effects related to this treatment include priapism, corporeal pain and the formation of nodules or plaques in the corpora cavernosa. Oral administration of drugs aimed at improving erectile function has not produced results comparable with those obtained with intracavernous injection therapy. However, in patients with psychogenic or mild organic impotence, oral treatment with drugs that influence either central or peripheral pathways controlling erection may improve erectile function. Topical administration of vasoactive drugs in the form of gels, liquid solutions or plasters is another attractive alternative for the treatment of psychogenic and mild organic erectile dysfunction. Although the ideal drug for the treatment of erectile dysfunction has not yet been identified, extensive laboratory and clinical research is ongoing and successful results are expected in the near future.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521769     DOI: 10.2165/00003495-199550030-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  51 in total

1.  Effect of apomorphine on penile tumescence in men with psychogenic impotence.

Authors:  R T Segraves; M Bari; K Segraves; P Spirnak
Journal:  J Urol       Date:  1991-06       Impact factor: 7.450

2.  Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases.

Authors:  R Virag; K Shoukry; J Floresco; F Nollet; E Greco
Journal:  J Urol       Date:  1991-02       Impact factor: 7.450

Review 3.  Consensus development conference statement. National Institutes of Health. Impotence. December 7-9, 1992.

Authors: 
Journal:  Int J Impot Res       Date:  1993-12       Impact factor: 2.896

4.  Intracavernous self-injection pharmacotherapy program: analysis of results and complications.

Authors:  R Valdevenito; A Melman
Journal:  Int J Impot Res       Date:  1994-06       Impact factor: 2.896

Review 5.  Bromocriptine in the treatment of hypogonadism and male impotence.

Authors:  C M March
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

6.  Topical minoxidil in the treatment of male erectile dysfunction.

Authors:  S B Radomski; S Herschorn; S Rangaswamy
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

Review 7.  Endocrine evaluation and therapy of erectile dysfunction.

Authors:  R D McClure
Journal:  Urol Clin North Am       Date:  1988-02       Impact factor: 2.241

Review 8.  Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine.

Authors:  M Zentgraf; M Baccouche; K P Jünemann
Journal:  Urol Int       Date:  1988       Impact factor: 2.089

9.  Efficiency and side effects of intracavernous injections of moxisylyte in impotent patients: a dose-finding study versus placebo.

Authors:  P Costa; B Sarrazin; F Bressolle; M H Colson; P Bondil; F Saudubray
Journal:  J Urol       Date:  1993-02       Impact factor: 7.450

10.  Effect of moxisylyte hydrochloride on isolated human penile corpus cavernosum tissue.

Authors:  A Imagawa; K Kimura; Y Kawanishi; M Tamura
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

View more
  4 in total

Review 1.  Comparative tolerability and efficacy of treatments for impotence.

Authors:  W Meinhardt; R F Kropman; P Vermeij
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 2.  Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.

Authors:  A P Lea; H M Bryson; J A Balfour
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

3.  Exploring scientifically proven herbal aphrodisiacs.

Authors:  Sabna Kotta; Shahid H Ansari; Javed Ali
Journal:  Pharmacogn Rev       Date:  2013-01

4.  Acute and subacute toxicity evaluation of hydroalcoholic extract from the stem bark of Bois Bande (Parinari campestris Aubl.1772) in rats.

Authors:  Venkatesan Sundaram; Stephanie Mohammed; M R Srinivasan; Jenelle Johnson; Rod Suepaul; Indira Pargass; Chernell John; Danesha Ramdhanie; Shiann Lallack; Esther Daniel; Lester Gilkes
Journal:  BMC Pharmacol Toxicol       Date:  2021-09-25       Impact factor: 2.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.